China Universal Asset Management Company’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $53.1K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $15.8K | Buy |
|
|||||
|
2024
Q2 | $9.21K | Sell |
|
|||||
|
2024
Q1 | $16.9K | Buy |
|
|||||
|
2023
Q4 | $8.61K | Buy |
|
|||||
|
2023
Q3 | $12.4K | Buy |
|
|||||
|
2023
Q2 | $9.6K | Buy |
|
|||||
|
2023
Q1 | $7.3K | Buy |
|
|||||
|
2022
Q4 | $10.7K | Buy |
|
|||||
|
2022
Q3 | $10K | Buy |
|